Home > Publications database > Tumor Neurobiology in the Pathogenesis and Therapy of Head and Neck Cancer. > print

001     287684
005     20241030145705.0
024 7 _ |2 doi
|a 10.3390/cells13030256
024 7 _ |2 pmid
|a pmid:38334648
024 7 _ |2 pmc
|a pmc:PMC10854684
037 _ _ |a DKFZ-2024-00312
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Liang, Siyuan
|b 0
245 _ _ |a Tumor Neurobiology in the Pathogenesis and Therapy of Head and Neck Cancer.
260 _ _ |a Basel
|b MDPI
|c 2024
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1707727970_28232
|x Review Article
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
500 _ _ |a #LA:E221#
520 _ _ |a The neurobiology of tumors has attracted considerable interest from clinicians and scientists and has become a multidisciplinary area of research. Neural components not only interact with tumor cells but also influence other elements within the TME, such as immune cells and vascular components, forming a polygonal relationship to synergistically facilitate tumor growth and progression. This review comprehensively summarizes the current state of the knowledge on nerve-tumor crosstalk in head and neck cancer and discusses the potential underlying mechanisms. Several mechanisms facilitating nerve-tumor crosstalk are covered, such as perineural invasion, axonogenesis, neurogenesis, neural reprogramming, and transdifferentiation, and the reciprocal interactions between the nervous and immune systems in the TME are also discussed in this review. Further understanding of the nerve-tumor crosstalk in the TME of head and neck cancer may provide new nerve-targeted treatment options and help improve clinical outcomes for patients.
536 _ _ |0 G:(DE-HGF)POF4-315
|a 315 - Bildgebung und Radioonkologie (POF4-315)
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |2 Other
|a TME
650 _ 7 |2 Other
|a head and neck cancer
650 _ 7 |2 Other
|a nerve–cancer crosstalk
650 _ 7 |2 Other
|a tumor neurobiology
700 1 _ |0 P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f
|a Hess, Jochen
|b 1
|e Last author
|u dkfz
773 _ _ |0 PERI:(DE-600)2661518-6
|a 10.3390/cells13030256
|g Vol. 13, no. 3, p. 256 -
|n 3
|p 256
|t Cells
|v 13
|x 2073-4409
|y 2024
856 4 _ |u https://inrepo02.dkfz.de/record/287684/files/cells-13-00256.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/287684/files/cells-13-00256.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:287684
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f
|a Deutsches Krebsforschungszentrum
|b 1
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF4-315
|1 G:(DE-HGF)POF4-310
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Krebsforschung
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2024
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b CELLS-BASEL : 2022
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2023-08-01T15:15:06Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2023-08-01T15:15:06Z
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Anonymous peer review
|d 2023-08-01T15:15:06Z
915 _ _ |0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|a Creative Commons Attribution CC BY (No Version)
|b DOAJ
|d 2023-08-01T15:15:06Z
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b CELLS-BASEL : 2022
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2023-10-26
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2023-10-26
920 2 _ |0 I:(DE-He78)E221-20160331
|k E221
|l Molekulare Grundlagen von HNO-Tumoren
|x 0
920 1 _ |0 I:(DE-He78)E221-20160331
|k E221
|l Molekulare Grundlagen von HNO-Tumoren
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E221-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21